Continuing Trastuzumab After Progression Shows Promise in HER2+ Gastric/GEJ Cancer
Continuing trastuzumab (Herceptin)-containing therapy beyond progression led to…
Browsing Tag
GastricGEJ
Another Win for Zolbetuximab in Advanced Gastric/GEJ Cancer
Zolbetuximab plus capecitabine and oxaliplatin (CAPOX) improved survival outcomes in…
Modest Survival Gain in Gastric/GEJ Cancer With Chemo Plus Pembrolizumab
Adding pembrolizumab (Keytruda) to chemotherapy modestly improved survival in…
Tislelizumab Plus Chemo for Advanced Gastric/GEJ Cancer
In this exclusive roundtable video from MedPage Today, three expert leaders in the field of…
Neoadjuvant Immunotherapy Combo Promising in Select Gastric/GEJ Cancers
At this year's American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, results…
SPOTLIGHT Results Show Promise for the Future of Gastric/GEJ Cancer Treatment
At the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, the results of the…
Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer
NEW ORLEANS -- More than 60% of patients with unresectable gastric/gastroesophageal junction (GEJ) cancer responded to the…